Regenxbio Inc (RGNX)
15.84
-0.17
(-1.06%)
USD |
NASDAQ |
May 20, 16:00
15.84
0.00 (0.00%)
After-Hours: 20:00
Regenxbio Accounts Payable (Quarterly): 31.36M for March 31, 2024
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 31.36M |
December 31, 2023 | 22.79M |
September 30, 2023 | 21.86M |
June 30, 2023 | 11.64M |
March 31, 2023 | 23.28M |
December 31, 2022 | 27.21M |
September 30, 2022 | 25.21M |
June 30, 2022 | 16.98M |
March 31, 2022 | 24.71M |
December 31, 2021 | 11.39M |
September 30, 2021 | 19.84M |
June 30, 2021 | 9.354M |
March 31, 2021 | 11.31M |
December 31, 2020 | 10.62M |
September 30, 2020 | 15.24M |
June 30, 2020 | 10.90M |
March 31, 2020 | 9.008M |
December 31, 2019 | 6.409M |
September 30, 2019 | 9.608M |
Date | Value |
---|---|
June 30, 2019 | 5.851M |
March 31, 2019 | 4.204M |
December 31, 2018 | 4.412M |
September 30, 2018 | 5.214M |
June 30, 2018 | 4.23M |
March 31, 2018 | 5.007M |
December 31, 2017 | 4.832M |
September 30, 2017 | 2.594M |
June 30, 2017 | 3.948M |
March 31, 2017 | 4.129M |
December 31, 2016 | 1.543M |
September 30, 2016 | 5.376M |
June 30, 2016 | 2.076M |
March 31, 2016 | 1.113M |
December 31, 2015 | 1.014M |
September 30, 2015 | 3.105M |
June 30, 2015 | 0.925M |
December 31, 2014 | 0.334M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
5.851M
Minimum
Jun 2019
31.36M
Maximum
Mar 2024
16.23M
Average
13.44M
Median
Accounts Payable (Quarterly) Benchmarks
Sarepta Therapeutics Inc | 91.54M |
AbbVie Inc | -- |
PTC Therapeutics Inc | 27.46M |
BridgeBio Pharma Inc | 4.728M |
Edgewise Therapeutics Inc | 4.723M |